Search Results

Momelotinib 25 mg  | 98.75%

TargetMol

Momelotinib is an orally bioavailable small-molecule inhibitor of Janus kinases 1 and 2 (JAK1/2) with IC50 of 11 nM/18 nM. JAK1/2 inhibitor CYT387 competes with JAK1/2 for ATP binding, which may result in inhibition of JAK1/2 activation, inhibition of the JAK-STAT signaling pathway, and so the induction of apoptosis and a reduction of tumor cell […]

More Information Supplier Page

Candesartan 100 mg  | 98.28%

TargetMol

Candesartan is an angiotensin II receptor blocker used widely in the therapy of hypertension and heart failure.

More Information Supplier Page

Rimonabant hydrochloride 25 mg  | Purity Not Available

TargetMol

Rimonabant hydrochloride (SR 141716A) is a cannabinoid receptor antagonist, binding selectively to central cannabinoid receptors (CB1) with high affinity.

More Information Supplier Page

Rimonabant hydrochloride 100 mg  | Purity Not Available

TargetMol

Rimonabant hydrochloride (SR 141716A) is a cannabinoid receptor antagonist, binding selectively to central cannabinoid receptors (CB1) with high affinity.

More Information Supplier Page

Vecuronium bromide 100 mg  | Purity Not Available

TargetMol

Vecuronium is a synthetic, intermediate-acting mono-quaternary steroid and non-depolarizing neuromuscular blocking agent, with muscle relaxant activity.

More Information Supplier Page

Vecuronium bromide 200 mg  | Purity Not Available

TargetMol

Vecuronium is a synthetic, intermediate-acting mono-quaternary steroid and non-depolarizing neuromuscular blocking agent, with muscle relaxant activity.

More Information Supplier Page

Nevirapine 200 mg  | 99.60%

TargetMol

Nevirapine is a benzodiazepine non-nucleoside reverse transcriptase inhibitor. In combination with other antiretroviral drugs, nevirapine reduces HIV viral loads and increases CD4 counts, thereby retarding or preventing the damage to the immune system and reducing the risk of developing AIDS.

More Information Supplier Page